When you work for a market maker what type of advice would you expect? What we have on one had is the advice from a PHD in biochemistry (if you believe him, he will not even publicly admit where it is from). VS 73 well qualified individuals, mostly Neurosurgeons, who have stated their credentials. Who have coauthored the Journal Article and who indicate DCVax-L with SOC exceed SOC treatment alone. We also know, as we have seen preliminary data with different check point inhibitors when combined with DCVax-L, that exceed the data from the trial.
What I don’t know is why we are talking to the Fool. He won’t even tell us where he purchased his degree from!
Bullish
Market Data 
Markets 
